Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
30 07 2019
Historique:
entrez: 31 7 2019
pubmed: 31 7 2019
medline: 17 6 2020
Statut: epublish

Résumé

Streptococcus pneumoniae (Spn) is a common cause of respiratory infection, but also frequently colonizes the nasopharynx in the absence of disease. We used mass cytometry to study immune cells from nasal biopsy samples collected following experimental human pneumococcal challenge in order to identify immunological mechanisms of control of Spn colonization. Using 37 markers, we characterized 293 nasal immune cell clusters, of which 7 were associated with Spn colonization. B cell and CD8+CD161+ T cell clusters were significantly lower in colonized than in non-colonized subjects. By following a second cohort before and after pneumococcal challenge we observed that B cells were depleted from the nasal mucosa upon Spn colonization. This associated with an expansion of Spn polysaccharide-specific and total plasmablasts in blood. Moreover, increased responses of blood mucosal associated invariant T (MAIT) cells against in vitro stimulation with pneumococcus prior to challenge associated with protection against establishment of Spn colonization and with increased mucosal MAIT cell populations. These results implicate MAIT cells in the protection against pneumococcal colonization and demonstrate that colonization affects mucosal and circulating B cell populations.

Identifiants

pubmed: 31361601
pii: 128865
doi: 10.1172/JCI128865
pmc: PMC6763269
doi:
pii:

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4523-4538

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M011569/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R005982/1
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Références

J Infect Dis. 2009 Sep 1;200(5):783-93
pubmed: 19642930
J Immunol Methods. 2014 Mar;405:97-108
pubmed: 24508527
JCI Insight. 2018 May 17;3(10):
pubmed: 29769438
Am J Respir Crit Care Med. 2015 Oct 1;192(7):853-8
pubmed: 26114410
Eur J Immunol. 2000 Oct;30(10):2972-9
pubmed: 11069080
Acta Pathol Microbiol Immunol Scand C. 1983 Dec;91(6):371-6
pubmed: 6201038
Sci Immunol. 2017 Jun 2;2(12):null
pubmed: 28783656
Cell Rep. 2017 Sep 19;20(12):2921-2934
pubmed: 28930685
J Infect Dis. 2009 Jul 1;200(1):99-106
pubmed: 19469705
Eur J Microbiol Immunol (Bp). 2012 Jun;2(2):112-20
pubmed: 24672679
PLoS One. 2017 Jan 20;12(1):e0169805
pubmed: 28107457
Front Immunol. 2018 Sep 07;9:1976
pubmed: 30245687
Infect Immun. 2013 Feb;81(2):392-401
pubmed: 23230294
J Immunol. 2005 Jun 1;174(11):6639-47
pubmed: 15905502
Infect Immun. 2004 Oct;72(10):5807-13
pubmed: 15385481
J Clin Invest. 2011 Sep;121(9):3666-76
pubmed: 21841315
J Proteome Res. 2018 Mar 2;17(3):1054-1064
pubmed: 29430923
Int Immunol. 2004 Jun;16(6):799-809
pubmed: 15096475
Nat Immunol. 2018 Dec;19(12):1299-1308
pubmed: 30374129
Cell. 2016 May 5;165(4):780-91
pubmed: 27153492
Thorax. 2012 Jan;67(1):71-9
pubmed: 20729232
Lancet. 2009 Sep 12;374(9693):893-902
pubmed: 19748398
MBio. 2011 May 17;2(3):e00016-11
pubmed: 21586648
Am J Respir Cell Mol Biol. 2016 Jan;54(1):13-24
pubmed: 26267148
Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4848-53
pubmed: 15781870
J Exp Med. 2018 May 7;215(5):1383-1396
pubmed: 29511064
J Infect Dis. 2018 Mar 5;217(6):988-999
pubmed: 29267892
Nat Microbiol. 2018 May;3(5):600-610
pubmed: 29662129
Nat Commun. 2017 Nov 23;8(1):1740
pubmed: 29170529
Mucosal Immunol. 2017 Jan;10(1):58-68
pubmed: 27143301
Nat Rev Microbiol. 2018 Jun;16(6):355-367
pubmed: 29599457
Nat Protoc. 2015 Feb;10(2):316-33
pubmed: 25612231
Genome Res. 2009 Sep;19(9):1639-45
pubmed: 19541911
PLoS Pathog. 2017 Dec 21;13(12):e1006665
pubmed: 29267378
J Neuroinflammation. 2012 Jan 02;9:1
pubmed: 22212381
J Infect Dis. 2005 Aug 1;192(3):387-93
pubmed: 15995951
Curr Opin Immunol. 2012 Aug;24(4):417-23
pubmed: 22658762
Vaccine. 2010 Nov 3;28(47):7468-75
pubmed: 20858450
Expert Rev Vaccines. 2012 Jul;11(7):841-55
pubmed: 22913260
PLoS Pathog. 2018 Oct 31;14(10):e1007396
pubmed: 30379943
PLoS Pathog. 2008 Sep 19;4(9):e1000159
pubmed: 18802458
Front Immunol. 2017 Dec 01;8:1711
pubmed: 29250077
Hum Vaccin Immunother. 2014;10(12):3688-99
pubmed: 25668673
Mucosal Immunol. 2017 Mar;10(2):385-394
pubmed: 27579859
PLoS One. 2014 Jan 30;9(1):e87400
pubmed: 24498098
Mucosal Immunol. 2018 Jul;11(4):1254-1264
pubmed: 29467446
J Exp Med. 2009 Mar 16;206(3):525-34
pubmed: 19273624
J Immunol. 2009 Feb 15;182(4):2231-40
pubmed: 19201877
J Vis Exp. 2013 Feb 15;(72):null
pubmed: 23439027
J Immunol. 2011 Oct 15;187(8):3931-41
pubmed: 21918187
N Engl J Med. 2003 May 1;348(18):1737-46
pubmed: 12724479
Semin Respir Crit Care Med. 2005 Dec;26(6):563-74
pubmed: 16388428
J Immunol. 2010 Sep 15;185(6):3652-60
pubmed: 20709949
J Immunol. 2006 Sep 1;177(5):2749-54
pubmed: 16920907
Nat Commun. 2018 Jan 17;9(1):253
pubmed: 29343684
J Exp Med. 2002 Feb 4;195(3):359-65
pubmed: 11828011
J Allergy Clin Immunol. 2013 Apr;131(4):933-57; quiz 958
pubmed: 23540615
J Immunol. 2008 Nov 1;181(9):6309-15
pubmed: 18941222
J Biol Chem. 1999 Dec 24;274(52):37329-34
pubmed: 10601300
Immunology. 2003 Mar;108(3):305-12
pubmed: 12603596
Epidemiol Infect. 2004 Jun;132(3):433-41
pubmed: 15188713
Am J Respir Crit Care Med. 2013 Apr 15;187(8):855-64
pubmed: 23370916
Science. 2012 Mar 16;335(6074):1376-80
pubmed: 22383809
J Infect Dis. 2008 Jun 1;197(11):1511-8
pubmed: 18471062
J Immunol. 2011 Jan 1;186(1):432-42
pubmed: 21135172
Nat Med. 1998 Jan;4(1):88-91
pubmed: 9427612
PLoS One. 2016 Feb 11;11(2):e0148826
pubmed: 26866695
J Exp Med. 2008 Aug 4;205(8):1903-16
pubmed: 18663128
J Leukoc Biol. 2015 Jan;97(1):31-8
pubmed: 25360000
Am J Respir Crit Care Med. 2016 Dec 15;194(12):1523-1531
pubmed: 27403678
Immunity. 2003 Jul;19(1):59-70
pubmed: 12871639
J Clin Invest. 2009 Jul;119(7):1899-909
pubmed: 19509469
Clin Microbiol Infect. 2014 Dec;20(12):O1145-51
pubmed: 24995531
J Immunol. 2003 Jan 15;170(2):686-94
pubmed: 12517929

Auteurs

Simon P Jochems (SP)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Department of Parasitology, Leiden University Medical Center, Leiden, Netherlands.

Karin de Ruiter (K)

Department of Parasitology, Leiden University Medical Center, Leiden, Netherlands.

Carla Solórzano (C)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Astrid Voskamp (A)

Department of Parasitology, Leiden University Medical Center, Leiden, Netherlands.

Elena Mitsi (E)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Elissavet Nikolaou (E)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Beatriz F Carniel (BF)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Sherin Pojar (S)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Esther L German (EL)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Jesús Reiné (J)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Alessandra Soares-Schanoski (A)

Bacteriology Laboratory, Butantan Institute, Sao Paulo, Brazil.

Helen Hill (H)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Royal Liverpool and Broadgreen University Hospital, Liverpool, United Kingdom.

Rachel Robinson (R)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Royal Liverpool and Broadgreen University Hospital, Liverpool, United Kingdom.

Angela D Hyder-Wright (AD)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Royal Liverpool and Broadgreen University Hospital, Liverpool, United Kingdom.

Caroline M Weight (CM)

Division of Infection and Immunity and.

Pascal F Durrenberger (PF)

Centre for Inflammation and Tissue Repair, University College London, London, United Kingdom.

Robert S Heyderman (RS)

Division of Infection and Immunity and.

Stephen B Gordon (SB)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Hermelijn H Smits (HH)

Department of Parasitology, Leiden University Medical Center, Leiden, Netherlands.

Britta C Urban (BC)

Department of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Jamie Rylance (J)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Andrea M Collins (AM)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Royal Liverpool and Broadgreen University Hospital, Liverpool, United Kingdom.
Aintree University Hospital NHS Foundation Trust, Liverpool, United Kingdom.

Mark D Wilkie (MD)

Royal Liverpool and Broadgreen University Hospital, Liverpool, United Kingdom.

Lepa Lazarova (L)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Royal Liverpool and Broadgreen University Hospital, Liverpool, United Kingdom.

Samuel C Leong (SC)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Department of Otorhinolaryngology - Head and Neck Surgery, Aintree University Hospital NHS Foundation Trust, Liverpool, United Kingdom.

Maria Yazdanbakhsh (M)

Department of Parasitology, Leiden University Medical Center, Leiden, Netherlands.

Daniela M Ferreira (DM)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH